DrugPatentWatch Database Preview
Drugs in Development Information for Danoprevir
What is the drug development status for Danoprevir?
Danoprevir is an investigational drug.
There have been 31 clinical trials for Danoprevir.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Hepatitis C, Chronic, Hepatitis C, and Hepatitis. The leading clinical trial sponsors are Hoffmann-La Roche, Ascletis Pharmaceuticals Co., Ltd., and [disabled in preview].
There are twenty-eight US patents protecting this investigational drug and four hundred and eighty-three international patents.
Summary for Danoprevir
| US Patents | 28 |
| International Patents | 483 |
| US Patent Applications | 48 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 43 |
Recent Clinical Trials for Danoprevir
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetics and Safety of Ravidasvir in Combination With Danoprevir/r in Healthy Volunteers China | Ascletis Pharmaceuticals Co., Ltd. | Phase 1 |
| Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r in Treatment-naive, Non-cirrhotic, Genotype1 CHC Patients. | Ascletis Pharmaceuticals Co., Ltd. | Phase 2/Phase 3 |
| Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China | Ascletis Pharmaceuticals Co., Ltd. | Phase 1 |
Clinical Trial Summary for Danoprevir
Top disease conditions for Danoprevir
Top clinical trial sponsors for Danoprevir
US Patents for Danoprevir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Danoprevir | Start Trial | Method for treating HCV | AbbVie Inc. (North Chicago, IL) | Start Trial |
| Danoprevir | Start Trial | Macrocyclic compounds as inhibitors of viral replication | Intermune, Inc. (Brisbane, CA) | Start Trial |
| Danoprevir | Start Trial | Macrocyclic inhibitors of hepatitis C virus replication | InterMune, Inc. (Brisbane, CA) | Start Trial |
| Danoprevir | Start Trial | Process for the preparation of a macrocycle | Roche Palo Alto LLC (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Danoprevir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Danoprevir | Australia | 2014239563 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | 2015240754 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | 2016202823 | 2033-03-14 | Start Trial |
| Danoprevir | Australia | 2016291154 | 2033-03-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
